Lexeo director granted options on 35,000 shares
Lexeo Therapeutics, Inc. director Timothy Van Hauwermeiren received a grant of stock options covering 35,000 shares of common stock.
Rhea-AI Filing Summary
Lexeo Therapeutics, Inc. director Timothy Van Hauwermeiren received a grant of stock options covering 35,000 shares of common stock. The options have an exercise price of $4.70 per share and expire on June 24, 2036. All 35,000 underlying shares will vest and become exercisable on the earlier of one year after the grant date or the next annual meeting of stockholders, assuming he continues in service through that date. Following this award, he holds options on 35,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 35,000 shares
Grant/Award
1 txn
Insider
Van Hauwermeiren Timothy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 35,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 35,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date.
Key Figures
Option grant size: 35,000 shares
Exercise price: $4.70 per share
Expiration date: June 24, 2036
+1 more
4 metrics
Option grant size
35,000 shares
Stock options on common stock granted to director
Exercise price
$4.70 per share
Stock option exercise price
Expiration date
June 24, 2036
Option expiry for granted stock options
Post-transaction options held
35,000 shares
Total derivative securities following transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, vest, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.7000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-24T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest financial
"100% of the shares underlying the option shall vest, and become exercisable"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"on the earlier of one year following the grant date or the next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Lexeo Therapeutics (LXEO) report for Timothy Van Hauwermeiren?
Lexeo Therapeutics reported that director Timothy Van Hauwermeiren received a grant of stock options for 35,000 shares. These options are a compensation award, not an open-market share purchase or sale, and give the right to buy common stock at a fixed price in the future.
What is the exercise price of the new Lexeo Therapeutics (LXEO) stock options?
The granted options have an exercise price of $4.70 per share. This means Van Hauwermeiren can buy Lexeo Therapeutics common stock at $4.70 if he exercises the options after they vest and before they expire, regardless of the market price at that time.
When do Timothy Van Hauwermeiren’s Lexeo Therapeutics (LXEO) options vest?
All 35,000 shares underlying the option will vest on the earlier of one year after the grant date or the next annual meeting of stockholders. Vesting requires his continuous service as a director through that vesting date, according to the Form 4 footnote.
When do the newly granted Lexeo Therapeutics (LXEO) stock options expire?
The stock options granted to Timothy Van Hauwermeiren expire on June 24, 2036. He can exercise them only after they vest and before this expiration date; after expiration, any unexercised options would no longer be usable to acquire shares.
How many Lexeo Therapeutics (LXEO) options does Timothy Van Hauwermeiren hold after this grant?
After this transaction, he holds stock options covering 35,000 shares of Lexeo Therapeutics common stock. This reflects the full amount of the new award reported, with no additional derivative positions shown in the filing’s derivative position summary section.
AI-generated analysis. How Rhea-AI works. Not financial advice.
